Connectively Wire

General

Press releases distributed to the journalists who cover the beat — through Connectively and national wire syndication.

Have news to distribute?

Write it, pick a category and the moment it crosses the wire, and reach the reporters already covering your industry. Your card is charged only when an editor approves the release.

Submit a press release
$250 per releaseEditorial guidelines
271 releases in the last 90 days262 issuers112 categories RSS
Latest release

More in General

Page 1 of 6

  1. Late-breaking Johnson & Johnson data in psoriatic arthritis (PsA) shows TREMFYA® (guselkumab) is the only advanced therapy to demonstrate MRI-confirmed improvements in spinal pain and stiffness

    TREMFYA® (guselkumab) showed statistically significant improvement in disease activity on the BASDAI score versus placebo, reflecting meaningful reductions in pain, stiffness, swelling and fatigue in a Phase 4 study1,2 Guselkumab demonstrated more than 2 times greater reduction…

    Johnson & Johnson